Le Lézard
Classified in: Health
Subject: MRR

Global Mini Bioreactors and Micro Bioreactors Markets, 2022-2035 - Growing Biopharmaceutical Pipeline Driving Growth

DUBLIN, Aug. 11, 2022 /PRNewswire/ -- The "Mini Bioreactors and Micro Bioreactors Market, Distribution by Type of Cell Culture, Mode of Operation, End User and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.


The 'Mini Bioreactors and Micro Bioreactors Market, 2022-2035' report features an extensive study of the current landscape and the likely future potential of minibioreactors and microbioreactors, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of minibioreactors and microbioreactors market. Based on multiple parameters, such as overall biopharmaceutical manufacturing market, overall single-use bioreactors market, share of minibioreactors and microbioreactors technologies, and likely adoption trends, we have provided an informed estimate of the evolution of the market for the period 2022-2035.

With several blockbuster therapies (such as Humira, Rituxan, Lantus, Avastin, Herceptin and Remicade) and a robust pipeline of product/therapy candidates, the biopharmaceutical market is anticipated to witness significant growth in the next few years.

Presently, more than 55 minibioreactors, developed by around 30 companies, are available for high-throughput media cultivation, process development and optimization. The stakeholders are taking several initiatives to incorporate a variety of features for monitoring of different control parameters, such as CO2 levels, dissolved oxygen, pH and temperature ranges, thereby allowing the users to analyze and determine essential conditions of the culture environment and optimize the overall performance.

Further, the growing interest in precision medicine has also brought up the demand for small-scale production and fast turn-around time of such products. Driven by the growing biopharmaceutical pipeline, the need for efficient and faster process development and manufacturing solutions, the overall minibioreactors market and microbioreactors market is anticipated to witness steady growth in the coming years.

Scope of the Report

Key Questions Answered

Key Topics Covered:

1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines


3.1. Chapter Overview
3.2. Overview of Minibioreactors and Microbioreactors
3.3. Advantages of Minibioreactors and Microbioreactors
3.4. Fabrication Materials for Minibioreactors and Microbioreactors
3.5. Future Perspectives

4.1. Chapter Overview
4.2. Minibioreactors and Microbioreactors: Overall Market Landscape
4.2.1. Analysis by Minimum Working Volume
4.2.2. Analysis by Maximum Working Volume
4.2.3. Analysis by Stirrer Speed
4.2.4. Analysis by Mode of Operations
4.2.5. Analysis by Usability
4.2.6. Analysis by Parameters Controlled
4.3. Minibioreactors and Microbioreactors Manufacturers: List of Industry Players
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Year of Establishment and Company Sie
4.3.5. Leading Manufacturers: Analysis by Number of Products

5.1. Chapter Overview
5.2. Eppendorf
5.2.1. Company Overview
5.2.2. Product Portfolio
5.2.3. Recent Developments and Future Outlook
5.3. Biosan
5.4. Bionet
5.5. Pall Corporation
5.6. Merck Millipore
5.7. Sartorius
5.8. Cytiva
5.9. Distek

6.1. Chapter Overview
6.2. Assumptions/Key Parameters
6.3. Methodology
6.4. Product Competitiveness Analysis: Minibioreactors and Microbioreactors

7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Minibioreactors and Microbioreactors: Patent Analysis

8.1. Chapter Overview
8.2. Forecast Methodology and Key Assumptions
8.3. Global Minibioreactors and Microbioreactors Market, 2022-2035
8.4. Global Minibioreactors and Microbioreactors Market: Distribution by Type of Cell Culture
8.5. Global Minibioreactors and Microbioreactors Market: Distribution by Mode of Operation
8.6. Global Minibioreactors and Microbioreactors Market: Distribution by Key Geographical Regions
8.7. Concluding Remarks

9.1. Chapter Overview
9.2. Single-use Bioreactors: List of Products
9.2.1. Analysis by Type of Bioreactor
9.2.2. Analysis by Scale of Operation
9.2.3. Analysis by Type of Cell Culture System
9.2.4. Analysis by Type of Cell Culture
9.2.5. Analysis by Type of Molecule Processed
9.2.6. Analysis by Key Features
9.2.7. Analysis by Application Area
9.2.8. Analysis by End Users
9.2.9. Analysis by Working Volume
9.3. Single-use Bioreactors: Developer Landscape
9.3.1. Analysis by Year of Establishment
9.3.2. Analysis by Company Size
9.3.3. Leading Developers: Analysis by Number of Single-use Bioreactors
9.3.4. Analysis by Location of Headquarters




For more information about this report visit https://www.researchandmarkets.com/r/3rkx6y

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]


For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900


U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg


SOURCE Research and Markets

These press releases may also interest you

at 21:02
Neuro Brands, LLC, a leader in the healthier lifestyle beverage space, including the high growth categories of refreshing energy, relaxation, sleep, daily and digestive health, has just announced the purchase of Ape #8585 for 777.0 ETH. Bored Ape...

at 20:32
As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital (TGH) Cancer Institute has established an adult Bone Marrow Transplant (BMT) and Cell Therapies unit that focuses on treating...

at 20:09
In response to a lawsuit filed by Siri & Glimstad LLP on behalf of the Informed Consent Action Network (ICAN), the CDC has released the first set of data from its v-safe program. V-safe is a smartphone-based program created by CDC specifically for...

at 19:30
Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pantherna Therapeutics GmbH (CEO:Klaus Giese, Ph.D., "Pantherna") today announced that the companies have entered into a new technology evaluation agreement for...

at 19:01
New research into the state of safety in UK workplaces has today been published by Draeger Safety UK. Key findings include: Positives: The...

at 19:01
Blue Shield of California today launched a public campaign asking Californians to speak up and make their voices heard by telling the state to undo its failed process for choosing health plans to serve Medi-Cal beneficiaries....

News published on 11 august 2022 at 09:45 and distributed by: